Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study.
Identifieur interne : 002D25 ( Main/Curation ); précédent : 002D24; suivant : 002D26Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study.
Auteurs : Douglas C. Bauer [États-Unis] ; Ann Schwartz [États-Unis] ; Lisa Palermo [États-Unis] ; Jane Cauley [États-Unis] ; Marc Hochberg [États-Unis] ; Art Santora [États-Unis] ; Steven R. Cummings [États-Unis] ; Dennis M. Black [États-Unis]Source :
- JAMA internal medicine [ 2168-6114 ] ; 2014.
Descripteurs français
- KwdFr :
- Absorptiométrie photonique, Adulte d'âge moyen, Agents de maintien de la densité osseuse (administration et posologie), Alendronate (administration et posologie), Densité osseuse, Femelle, Fractures osseuses (), Fractures osseuses (épidémiologie), Humains, Marqueurs biologiques (sang), Phosphatase alcaline (sang), Prévision, Sujet âgé, Sujet âgé de 80 ans ou plus, États-Unis d'Amérique (épidémiologie), Études prospectives.
- MESH :
- administration et posologie : Agents de maintien de la densité osseuse, Alendronate.
- sang : Marqueurs biologiques, Phosphatase alcaline.
- épidémiologie : Fractures osseuses, États-Unis d'Amérique.
- Absorptiométrie photonique, Adulte d'âge moyen, Densité osseuse, Femelle, Fractures osseuses, Humains, Prévision, Sujet âgé, Sujet âgé de 80 ans ou plus, Études prospectives.
- Wicri :
- geographic : États-Unis.
English descriptors
- KwdEn :
- Absorptiometry, Photon, Aged, Aged, 80 and over, Alendronate (administration & dosage), Alkaline Phosphatase (blood), Biomarkers (blood), Bone Density, Bone Density Conservation Agents (administration & dosage), Female, Forecasting, Fractures, Bone (epidemiology), Fractures, Bone (prevention & control), Humans, Middle Aged, Prospective Studies, United States (epidemiology).
- MESH :
- chemical , administration & dosage : Alendronate, Bone Density Conservation Agents.
- chemical , blood : Alkaline Phosphatase, Biomarkers.
- geographic , epidemiology : United States.
- epidemiology : Fractures, Bone.
- prevention & control : Fractures, Bone.
- Absorptiometry, Photon, Aged, Aged, 80 and over, Bone Density, Female, Forecasting, Humans, Middle Aged, Prospective Studies.
Abstract
Discontinuation of bisphosphonate therapy after 3 to 5 years is increasingly considered, but methods to monitor fracture risk after discontinuation have not been established.
DOI: 10.1001/jamainternmed.2014.1232
PubMed: 24798675
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002508
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002498
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002498
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001E69
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :001E69
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001E69
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :002E56
Links to Exploration step
pubmed:24798675Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study.</title>
<author><name sortKey="Bauer, Douglas C" sort="Bauer, Douglas C" uniqKey="Bauer D" first="Douglas C" last="Bauer">Douglas C. Bauer</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Medicine, University of California, San Francisco2Department of Epidemiology and Biostatistics, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Department of Medicine, University of California, San Francisco2Department of Epidemiology and Biostatistics, University of California</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Schwartz, Ann" sort="Schwartz, Ann" uniqKey="Schwartz A" first="Ann" last="Schwartz">Ann Schwartz</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Department of Epidemiology and Biostatistics, University of California</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Palermo, Lisa" sort="Palermo, Lisa" uniqKey="Palermo L" first="Lisa" last="Palermo">Lisa Palermo</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Department of Epidemiology and Biostatistics, University of California</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Cauley, Jane" sort="Cauley, Jane" uniqKey="Cauley J" first="Jane" last="Cauley">Jane Cauley</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hochberg, Marc" sort="Hochberg, Marc" uniqKey="Hochberg M" first="Marc" last="Hochberg">Marc Hochberg</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">Baltimore</settlement>
<region type="state">Maryland</region>
</placeName>
<wicri:orgArea>Department of Epidemiology and Public Health, University of Maryland School of Medicine</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Santora, Art" sort="Santora, Art" uniqKey="Santora A" first="Art" last="Santora">Art Santora</name>
<affiliation wicri:level="2"><nlm:affiliation>Merck and Co, Inc, Rahway, New Jersey.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Merck and Co, Inc, Rahway</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Cummings, Steven R" sort="Cummings, Steven R" uniqKey="Cummings S" first="Steven R" last="Cummings">Steven R. Cummings</name>
<affiliation wicri:level="2"><nlm:affiliation>California Pacific Research Foundation, San Francisco, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>California Pacific Research Foundation, San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Black, Dennis M" sort="Black, Dennis M" uniqKey="Black D" first="Dennis M" last="Black">Dennis M. Black</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Department of Epidemiology and Biostatistics, University of California</wicri:orgArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24798675</idno>
<idno type="pmid">24798675</idno>
<idno type="doi">10.1001/jamainternmed.2014.1232</idno>
<idno type="wicri:Area/PubMed/Corpus">002508</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002508</idno>
<idno type="wicri:Area/PubMed/Curation">002498</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002498</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002498</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002498</idno>
<idno type="wicri:Area/Ncbi/Merge">001E69</idno>
<idno type="wicri:Area/Ncbi/Curation">001E69</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001E69</idno>
<idno type="wicri:Area/Main/Merge">002E56</idno>
<idno type="wicri:Area/Main/Curation">002D25</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study.</title>
<author><name sortKey="Bauer, Douglas C" sort="Bauer, Douglas C" uniqKey="Bauer D" first="Douglas C" last="Bauer">Douglas C. Bauer</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Medicine, University of California, San Francisco2Department of Epidemiology and Biostatistics, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Department of Medicine, University of California, San Francisco2Department of Epidemiology and Biostatistics, University of California</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Schwartz, Ann" sort="Schwartz, Ann" uniqKey="Schwartz A" first="Ann" last="Schwartz">Ann Schwartz</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Department of Epidemiology and Biostatistics, University of California</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Palermo, Lisa" sort="Palermo, Lisa" uniqKey="Palermo L" first="Lisa" last="Palermo">Lisa Palermo</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Department of Epidemiology and Biostatistics, University of California</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Cauley, Jane" sort="Cauley, Jane" uniqKey="Cauley J" first="Jane" last="Cauley">Jane Cauley</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hochberg, Marc" sort="Hochberg, Marc" uniqKey="Hochberg M" first="Marc" last="Hochberg">Marc Hochberg</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">Baltimore</settlement>
<region type="state">Maryland</region>
</placeName>
<wicri:orgArea>Department of Epidemiology and Public Health, University of Maryland School of Medicine</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Santora, Art" sort="Santora, Art" uniqKey="Santora A" first="Art" last="Santora">Art Santora</name>
<affiliation wicri:level="2"><nlm:affiliation>Merck and Co, Inc, Rahway, New Jersey.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Merck and Co, Inc, Rahway</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Cummings, Steven R" sort="Cummings, Steven R" uniqKey="Cummings S" first="Steven R" last="Cummings">Steven R. Cummings</name>
<affiliation wicri:level="2"><nlm:affiliation>California Pacific Research Foundation, San Francisco, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>California Pacific Research Foundation, San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Black, Dennis M" sort="Black, Dennis M" uniqKey="Black D" first="Dennis M" last="Black">Dennis M. Black</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Department of Epidemiology and Biostatistics, University of California</wicri:orgArea>
</affiliation>
</author>
</analytic>
<series><title level="j">JAMA internal medicine</title>
<idno type="eISSN">2168-6114</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Absorptiometry, Photon</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Alendronate (administration & dosage)</term>
<term>Alkaline Phosphatase (blood)</term>
<term>Biomarkers (blood)</term>
<term>Bone Density</term>
<term>Bone Density Conservation Agents (administration & dosage)</term>
<term>Female</term>
<term>Forecasting</term>
<term>Fractures, Bone (epidemiology)</term>
<term>Fractures, Bone (prevention & control)</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>United States (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Absorptiométrie photonique</term>
<term>Adulte d'âge moyen</term>
<term>Agents de maintien de la densité osseuse (administration et posologie)</term>
<term>Alendronate (administration et posologie)</term>
<term>Densité osseuse</term>
<term>Femelle</term>
<term>Fractures osseuses ()</term>
<term>Fractures osseuses (épidémiologie)</term>
<term>Humains</term>
<term>Marqueurs biologiques (sang)</term>
<term>Phosphatase alcaline (sang)</term>
<term>Prévision</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>États-Unis d'Amérique (épidémiologie)</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Alendronate</term>
<term>Bone Density Conservation Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Alkaline Phosphatase</term>
<term>Biomarkers</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Agents de maintien de la densité osseuse</term>
<term>Alendronate</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Fractures, Bone</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Fractures, Bone</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Marqueurs biologiques</term>
<term>Phosphatase alcaline</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Fractures osseuses</term>
<term>États-Unis d'Amérique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Absorptiometry, Photon</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Bone Density</term>
<term>Female</term>
<term>Forecasting</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Absorptiométrie photonique</term>
<term>Adulte d'âge moyen</term>
<term>Densité osseuse</term>
<term>Femelle</term>
<term>Fractures osseuses</term>
<term>Humains</term>
<term>Prévision</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Discontinuation of bisphosphonate therapy after 3 to 5 years is increasingly considered, but methods to monitor fracture risk after discontinuation have not been established.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D25 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 002D25 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Amérique |area= PittsburghV1 |flux= Main |étape= Curation |type= RBID |clé= pubmed:24798675 |texte= Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:24798675" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a PittsburghV1
This area was generated with Dilib version V0.6.38. |